The PennZone

  • Home
  • Business
  • Health
  • Education
  • Entertainment
  • Financial
  • Legal
  • Non-profit
  • Music

Nattokinase Supplement for Cardiovascular and Circulatory Support
The PennZone/10270754

Trending...
  • Pray the News Launches to Transform American Christians' Relationship with News
  • IRF Builders Forum Brings Global Leaders to Washington, D.C. to Advance Religious Freedom Through Cooperative Engagement
  • Penn Mutual Earns 2025 Great Place To Work Certification™
Nattokinase Heart Health Supplement
AgeImmune's Nattokinase is one of the purest professional grade supplement on the market which is beneficial for overall heart health.

NEW YORK - PennZone -- Dr. Kanevsky, D.C. C.F.M.P. introduced a new supplement to AgeImmune's product line
earlier this May 2024.
A new addition to the family is Nattokinase supplement in a form of a vegetable capsule
each containing 2,000FU (fibrin unit) representing a unit of potency, which is equal to
100mg. Dr. Kanevsky is recommending a serving size of 2 capsules. However, if you
are in excellent heart health with no family history of blood clots, 1 capsule is enough as
a preventative measure.
Nattokinase is an enzyme derived from Japanese soybean called Natto via fermentation
process with a bacteria called Bacillus subtilis. Natto has been consumed as a
traditional food in Asia for over 2000 years and is believed to be a significant contributor

More on The PennZone
  • $796,000 in Q2 Revenue Marks Highest Earnings to Date on 3 Trailing Quarters of Profitability in Multi-Billion Homebuilding Sector: Stock Symbol: IVDN
  • Cybersecurity is THE Hot Market Sector; Revenues, Earnings & Profit matter; Only 33 Million Shares + a Huge Short Position Equal an Undervalued Stock
  • Despite Global Calls for a Ban, US Child Psychiatry Pushes Electroshock for Kids
  • BeyondTrucks CEO Wins Gold Stevie® Award for Best Entrepreneur in Transportation
  • Franco Polished Plaster Celebrates 35 Years of Bringing Walls to Life in the UK

to the longevity of the Japanese people. Although natto has been consumed in Asia for
thousands of years, the fibrinolytic and antithrombolytic property of Nattokinasae was
only discovered in 1987. Recent studies demonstrated that high natto intake is
associated with decreased risk of cardiovascular disease.
This was a sufficient reason for Dr. Kanevsky to add Nattokinase to his line of products.
There is some early evidence that nattokinase may thin the blood and help break up
blood clots. This might protect against heart disease and conditions caused by blood
clots such as stroke, heart attack, and others.
Other studies show that nattokinase may help lower blood pressure and reduce
inflammation in the body.
Unlike traditional blood thinning medications, nattokinase is a natural, widely available
and inexpensive supplement with minimal to no side effects which makes is very

More on The PennZone
  • Spartan & Guardians Partner with Guitar Legend Buckethead to Support Global Child Rescue Efforts
  • C8C.AI Launches Audio Compliance Engine to Streamline Ethical AI Audio Data at Scale
  • Preliminary.online Introduces Short-Term Job-Readiness Courses with Employer-Verified Certifications
  • Psychologist-Turned-Hermeticist Releases Modern Guide to the Seven Hermetic Principles
  • Winners Announced for Asia Pacific Business Awards 2024-2025

attractive to Dr. Kanevsky's patients searching for an all-natural approach to their
health.
Having a large database of functional medicine patients Dr Kanevsky easily analyzed
the frequency of complains of a poor heart health, circulation, blood pressure and came
to a conclusion that Nattokinase will become one of the most popular products for
AgeImmune.
As always encapsulated without harmful excipients such as magnesium stearate, silicon
dioxide or titanium dioxide, AgeImmune's Nattokinase is one of the purest professional
grade supplement on the market.
Nattokinase supplement is derived from soy. Dr. Kanevsky warns that if you are allergic
to soy, you shouldn't be taking Nattokinase. It is currently available for purchase at a
discounted price of 21.99 on AgeImmune's website and on Amazon

Contact
AgeImmine
***@netembark.com


Source: Nattokinase Heart Health Supplement
Filed Under: Health

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • $10 Million Acquisition of GXR World Sports Assets Energizes Global Launch of Sports.com Super App by Online Lottery-Sports Game Provider: Lottery.com
  • Shop American Made Goods: New Online Marketplace My American Goods Curates the Best of U.S. Made
  • Penn Mutual Earns 2025 Great Place To Work Certification™
  • Investor Spotlight: Cycurion, Inc. (N A S D A Q: CYCU) Secures $69M in Contracts Amid Surging Demand for AI-Powered Cybersecurity Solutions
  • $328 Million Global Stroke Rehab Market Opportunity Awaits AI Telehealth Leader Following Selection for NIH Funded Phase 3 Clinical Study: VSee Health
  • Ascent Solar Technologies Enters Collaborative Agreement Notice with NASA to Advance Development of Thin-Film PV Power Beaming Capabilities: ASTI
  • VoodooSoft Unveils SiriusLLM: The World's First ChatGPT-Like AI Malware Detection Engine
  • This Ain't Press. This Is Pressure — Star Command by RansomXX is Out Now
  • An Exclusive VIP Reception Honoring Vocal Prodigy Alliana Lili Yang's Remarkable Achievements and Magazine Cover Spotlight
  • Joyce Carol Oates Returns to Hard Case Crime With DOUBLE TROUBLE
  • New AI Academy Helps Therapists Embrace Tech Without Losing Their Humanity
  • Watch Out for Deed and Title Fraud Warns PA Association of Realtors®
  • IQSTEL Surges Toward $400M Run Rate with $101.5M in Revenue—Reinforces Billion-Dollar Vision Backed by Fintech, AI, and Cybersecurity
  • Alpha Modus Files 7th IP Action Against Rackspace Following $3M CEO Investment and Strategic Partnership Expansion
  • Mortgage Rates And Demand Are Stuck In A Holding Pattern
  • Coker Completes Acquisition of Healthcare Cost Solutions, a Leading Expert in Technology-Enabled Compliance Services
  • Keepy Uppy™ by Ollyball Wins Prestigious 2025 Influencer Award from Clamour & The Toy Association; Announces Fall 2025 Launch at Target Stores
  • K2 Integrity's U.S. and EMEA Teams Recognized in Chambers and Partners 2025 Guides
  • A rare chance to own a multi-family property in the heart of Bay Ridge
  • LA Laura Paris Drops Underground Girl Remixes

Popular on PennZone

  • AI in Healthcare Just Crossed a Tipping Point. Investors Are Watching These Names - 166
  • Garage Door Scam Alert: Superior Overhead Doors Warns Tulsa Homeowners About Red Flags - 103
  • A World First: The Global Naturism & Nudism Index Launched by NaturismRE™
  • Handel's Ice Cream Celebrates Grand opening Event in Rialto, California
  • Real Estate CEO Launches Explosive New Book After $275,784 Wire Fraud Incident
  • Western Carolina Emergency Network Accepts 2025 ReadyCommunities Partnership/CCROA National Service Award for Collaboration to Augment Local Response
  • JMC Princess Announces Release of Empowering New Single "PRETTY" – A Summer Anthem for Young Girls Everywhere
  • RNHA Named Official Community Partner of the First Annual CPAC Latino 2025
  • Kaplan Morrell Applauds Passage of Landmark Workers' Compensation Reform in Colorado
  • Rediscovered Christopher Lee Recording 'Elenore' Re-Released to Mark 10th Anniversary of His Passing

Similar on PennZone

  • Despite Global Calls for a Ban, US Child Psychiatry Pushes Electroshock for Kids
  • Preliminary.online Introduces Short-Term Job-Readiness Courses with Employer-Verified Certifications
  • Medwave Recognized Among Top 10 Medical Billing Companies in USA by MedicoLeads
  • Shop American Made Goods: New Online Marketplace My American Goods Curates the Best of U.S. Made
  • $328 Million Global Stroke Rehab Market Opportunity Awaits AI Telehealth Leader Following Selection for NIH Funded Phase 3 Clinical Study: VSee Health
  • New AI Academy Helps Therapists Embrace Tech Without Losing Their Humanity
  • Coker Completes Acquisition of Healthcare Cost Solutions, a Leading Expert in Technology-Enabled Compliance Services
  • Keepy Uppy™ by Ollyball Wins Prestigious 2025 Influencer Award from Clamour & The Toy Association; Announces Fall 2025 Launch at Target Stores
  • $750 Million Ketamine Drug Market Withing Reach via New Commissioner's National Priority Vouchers with Anticipated Approval by Year-End for NRx
  • NUFABRX awarded Therapeutic Compression agreement with Premier, Inc
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us